Maaz advises leading biopharmaceutical and other life sciences clients in value, pricing and access strategy as well as commercial and other cross-functional strategic projects. He has extensive experience across therapeutic areas, including oncology, hematology, respiratory, and across therapeutic modalities, including gene therapies. His expertise spans new product development and indication planning decisions, value proposition development and evidence planning, go-to-market pricing and market access strategy, and stakeholder engagement and lifecycle management. In addition to his strategic consulting experience, he also has in-depth industry experience obtained via an extensive secondment with a client global access and value team supporting a multi-country product launch.
Maaz earned his MSc in Management from the London School of Economics and graduated with a degree in Medicine from St George’s University of London. Prior to joining Putnam, Maaz held position of ascending responsibility in other strategic pricing and market access consultancy.